首页|盐酸左沙丁胺醇雾化吸入溶液空气动力学粒径分布体外一致性评价

盐酸左沙丁胺醇雾化吸入溶液空气动力学粒径分布体外一致性评价

扫码查看
目的 研究盐酸左沙丁胺醇雾化吸入溶液的空气动力学粒径分布(APSD),并采用群体生物等效统计方法评价受试制剂与参比制剂在质量标准范围内的APSD的一致性.方法 使用新一代药用多级撞击器(NGI)测定盐酸左沙丁胺醇雾化吸入溶液的APSD,分别对含量为标示量的100%的受试制剂与参比制剂及含量为标示量的85%,90%及110%的受试制剂与参比制剂进行APSD一致性评价.结果 含量在标示量90%~110%范围内的受试制剂与参比制剂APSD各指标对比均满足Hη<0,表明受试制剂与参比制剂等效.结论 成功建立了盐酸左沙丁胺醇雾化吸入溶液的APSD测定方法,可为雾化吸入溶液剂的质量一致性评价提供参考.
Evaluation of In Vitro Equivalence of Aerodynamic Particle Size Distribution of Levalbuterol Hydrochloride Inhalation Solution
Objective To study the aerodynamic particle size distribution(APSD)of Levalbuterol Hydrochloride Inhalation Solution,and evaluate the consistency of APSD between the test preparation and the reference preparation within the range required by the quality standard through population bioequivalence statistical test.Methods The APSD of Levalbuterol Hydrochloride Inhalation Solution was determined by next generation impactor(NGI),and the APSD consistency of the test preparation and the reference preparation with the content of 100%of the labeled amount and the test preparation and the reference preparation with the content of 85%,90%and 110%of the labeled amount were evaluated.Results Compared with the APSD indexes of the reference preparation,the test preparation met Hη<0 in the content range of 90%-1 10%of the labeled amount,indicating that the test preparation was equivalent to the reference preparation.Conclusion The APSD determination method of Levalbuterol Hydrochloride Inhalation Solution is successfully established,which can provide a reference for the quality consistency evaluation of nebulized inhalation solution.

Levalbuterol Hydrochloride Inhalation Solutionaerodynamic particle size distributionin vitro population bioequivalence statistical analysisconsistency evaluation

周峰、丁文雅

展开 >

广西中医药大学药学院,广西南宁 530200

深圳大佛药业股份有限公司,广东 深圳 518122

广西高校中药制剂共性技术研发重点实验室,广西南宁 530200

盐酸左沙丁胺醇雾化吸入溶液 空气动力学粒径分布 体外群体生物等效统计分析 一致性

2024

食品与药品
山东省生物药物研究院

食品与药品

CSTPCD
影响因子:0.537
ISSN:1672-979X
年,卷(期):2024.26(6)